Significant biopharmaceutical company, anchored in Japan, with a global reach
Sosei is a Japanese listed, international biopharmaceutical company, with near term sustainable revenue from products out-licensed from its product portfolio.
From its inception Sosei has had global aspirations and operated internationally linking Japan with the west.
Operating on a cross-border basis is a challenge which Sosei has embraced. It is an integral part of its evolving business model, leading ultimately towards making a significant contribution to improving the quality of life and health of people around the world.
As the pharmaceutical industry environment changes Sosei seeks to adapt without losing its focus on the successful reprofiling, development and commercialisation of its compounds and its aim to become a significant biopharmaceutical company which capitalises upon its unique Anglo-Japanese operations.
